TLCR Reading Tools
How to cite item
Biomarker analysis of the phase II JO25567 study comparing erlotinib with or without bevacizumab in first-line advanced
EGFR
+
non-small-cell lung cancer
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{75941}, author = {Nishio, M., Atagi, S., Goto, K., Hosomi, Y., Seto, T., Hida, T., Nakagawa, K., Yoshioka, H., Nogami, N., Maemondo, M., Nagase, S., Okamoto, I., Yamamoto, N., Igawa, Y., Tajima, K., Fukuoka, M., Yamamoto, N., Nishio, K.}, title = {Biomarker analysis of the phase II JO25567 study comparing erlotinib with or without bevacizumab in first-line advanced <em>EGFR</em><sup>+</sup> non-small-cell lung cancer}, journal = {Translational Lung Cancer Research}, volume = {12}, number = {6}, year = {2023}, url = {https://tlcr.amegroups.org/article/view/75941} }